J Biol Chem, Vol. 274, Issue 32, 22151-22154, August 6, 1999

COMMUNICATION
The RING Finger of c-Cbl Mediates Desensitization of the Epidermal Growth Factor Receptor^*

Hadassa Waterman, Gil Levkowitz, Iris Alroy, and Yosef Yarden

From the Department of Biological Regulation, The Weizmann Institute of Science, Rehovot 76100, Israel

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

Ligand-induced activation of surface receptors, including the epidermal growth factor receptor (EGFR), is followed by a desensitization process involving endocytosis and receptor degradation. c-Cbl, a tyrosine phosphorylation substrate shared by several signaling pathways, accelerates desensitization by recruiting EGFR and increasing receptor polyubiquitination. Here we demonstrate that the RING type zinc finger of c-Cbl is essential for ubiquitination and subsequent desensitization of EGFR. Mutagenesis of a single cysteine residue impaired the ability of c-Cbl to enhance both down-regulation and ubiquitination of EGFR in living cells, although the mutant retained binding to the activated receptor. Consequently, the mutant form of c-Cbl acquired a dominant inhibitory function and lost the ability to inhibit signaling downstream to EGFR. In vitro reconstitution of EGFR ubiquitination implies that the RING finger plays an essential direct role in ubiquitin ligation. Our results attribute to the RING finger of c-Cbl a causative role in endocytic sorting of EGFR and desensitization of signal transduction.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

We have reported recently that c-Cbl can accelerate the rate of EGFR¹ degradation by increasing conjugation of polyubiquitin to an endocytosed EGFR (1). Consistent with sorting to degradation, genetic studies in Caenorhabditis elegans attributed a negative regulatory role to Sli-1, the c-Cbl ortholog of worms (2). This function is reminiscent of the action of c-Cbl downstream to the PGDFR (3), and it depends on a catalytically intact kinase domain of EGFR. The present study addressed the structural motif of c-Cbl involved in ubiquitination of EGFR. Although the 120-kDa c-Cbl protein possesses no identifiable catalytic activity, its NH₂-terminal half carries a novel phosphotyrosine-binding domain (PYB) (4), that presumably mediates binding to the activated receptor (5). The carboxyl terminus of c-Cbl comprises several proline-rich tracts that allow constitutive binding of Src homology 3 (SH3)-containing proteins, such as Grb2, Nck, and the Cbl-associated protein, CAP (reviewed in Ref. 6). In addition, the COOH terminus is involved in inducible interactions with SH2-containing proteins, such as the regulatory subunit of the phosphoinositide 3-kinase, and the guanine nucleotide exchange protein Vav. An evolutionarily conserved RING-type zinc finger domain separates the adaptor domains of c-Cbl. RING fingers (RFs) are zinc-binding domains that differ from other zinc finger motifs in terms of structure and the zinc ligation scheme (reviewed in Ref. 7). Noteworthy is the fact that the two other family members of c-Cbl carry an intact RF (8, 9), but oncogenic Cbl variants are defective in the RF (10, 11). Our present study concentrated on the role the RF motif plays in Cbl-mediated degradation of EGFR.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

Materials, Buffers, and Antibodies-- EGF was purchased from Sigma, and radioactive materials were from Amersham Pharmacia Biotech (Buckinghamshire, United Kingdom). Rabbit anti-c-Cbl (C-15) antibodies, anti-EGFR, and a monoclonal antibody (mAb) to phosphotyrosine were from Santa Cruz Biotechnology (Santa Cruz, CA). A mAb to the active doubly phosphorylated form of Erk was from Sigma. The compositions of TBST, HNTG, binding-binding and solubilization buffers were as described (12). Ubiquitin was radiolabeled by using IODO-GEN (Pierce) and Na¹²⁵I.

Construction and Transfection of Expression Vectors-- We have previously described the construction of c-Cbl, 70Z-Cbl, and v-Cbl in the pCDNA3 expression vector (Invitrogen) containing the HA sequence tag (13). To generate C381A-Cbl (cysteine 381 mutated to an alanine), we used the Stratagene Quick-change mutagenesis kit. The ubiquitin-hemagglutinin A (Ub-HA) expression vector was a gift from Dirk Bohmann (EBI, Heidelberg, Germany). The protocols for transfection of CHO cells were exactly as described (1). A bacterial pGEX4T2 expression vector (Amersham Pharmacia Biotech) was used for expression of GST-Cbl proteins. GST-fusion proteins were affinity-purified on gluthatione-agarose as described previously (13).

Lysate Preparation, Immunoprecipitation, and Western Blotting-- Whole cell lysates were cleared by centrifugation (12,000 × g, 10 min) and analyzed either directly or after immunoprecipitation by SDS-PAGE and immunoblotting as described (12). Protein bands were detected with an enhanced chemiluminescence reagent (Amersham Pharmacia Biotech).

Receptor Down-regulation and Phosphorylation Assays-- Down-regulation of EGFR was assayed as described (12). For in vitro kinase assays, EGFR immunoprecipitates were incubated for 15 min on ice in HNTG containing 5 mM MnCl₂ and 0.01 µCi of [-³²P]ATP. The immobilized immunocomplexes were then washed and resolved by SDS-PAGE.

SRE Transcription Assay-- Transfection of the indicated vectors was performed in triplicates with a reporter pSRE-Fluc plasmid (4 µg), containing one copy of the SRE cloned upstream to the Fos minimal promoter (nucleotides 53/+45) and the luciferase gene (14). Twenty-four hours later, cells were treated with EGF (20 ng/ml) or left untreated for 12 h. Whole cell extracts were prepared by resuspending the cells in 30 µl of 1 × lysis buffer (Promega). Cellular debris were removed and a 10-µl aliquot mixed with 100 µl of luciferin buffer (0.1 M Tris acetic acid, 10 mM magnesium acetate, 1 mM EDTA, pH 8.0, 74 mM luciferin, and 2.2 µM ATP). Light intensity was measured by using a luminometer. The results were normalized to protein concentrations.

In Vitro Ubiquitination Assay-- EGFR was immunoprecipitated from A-431 cell lysates with an agarose-immobilized mAb SG565 and used as a substrate. Following purification, agarose beads were extensively washed and resuspended in a buffer containing 40 mM Tris-HCl, pH 7.5, 5 mM MgCl₂, 2 mM dithiothreitol, 2 mM ATPS, and ¹²⁵I-labeled ubiquitin (3 µg/ml). To deplete endogenous ATP, we added hexokinase (1 mg/ml) and 2-deoxyglucose (20 mM). Crude rabbit reticulocyte lysate (5 µl, from Promega) was added to the reactions. Reaction mixtures were supplemented with GST fusion proteins as indicated (5 µg) and incubated for 1 h at 30 °C. The beads were then extensively washed and EGFR eluted with SDS-PAGE sample buffer prior to electrophoresis.

	RESULTS AND DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

Mutagenesis of the RING Finger Impairs Cbl-induced Down-regulation of EGFR-- The recently reported ability of c-Cbl to enhance degradation of the EGFR (1) and the platelet-derived growth factor receptor (3) can explain the phenotype of Sli-1 mutant worms (2), but they leave open the mechanism underlying increased ubiquitination and degradation. For several reasons we suspected that the RF domain of c-Cbl is involved in ubiquitination. First, the centrally located RF is flanked on both sides by functional adaptor domains, but its own activity is unknown. Second, the RF-defective oncogenic forms of c-Cbl, namely: the CAS NS-1 retrovirus-encoded v-Cbl (11) and the 70Z-Cbl of pre-B cell lymphoma (10), cannot mediate accelerated degradation of EGFR (1). Third, the RFs of several proteins, for example the corresponding region of the DCC (deleted in colon cancer)-binding protein, Siah (15), can promote proteolysis via the ubiquitin-proteasome pathway. To test involvement of the RF, we mutated cysteine 381, the first cysteine of the C₃HC₄ zinc finger motif, to an alanine. This mutation is expected to completely disrupt site-1 of the cross-brace zinc ligation motif (7). The ability of the mutant protein, which we denoted C381A-Cbl, to affect ligand-induced removal of EGFR from the cell surface ("down-regulation") was compared with that of the wild type c-Cbl and its two oncogenic variants. CHO cells expressing no endogenous EGFR were co-transfected with an EGFR expression vector, along with Cbl-encoding plasmids. The results presented in Fig. 1A demonstrate that while c-Cbl overexpression caused remarkable acceleration of ligand-induced clearance of EGFR from the cell surface, the two oncogenic form of c-Cbl as well as the RF mutant could not enhance receptor disappearance (Fig. 1A). To substantiate the effect on down-regulation, we examined the effect of C381A-Cbl on EGFR degradation and ubiquitination. In accord with our previous results, c-Cbl overexpression induced both limited degradation of EGFR and up-smearing of the protein band (Fig. 1B, upper panel). Both C381A-Cbl and 70Z-Cbl were inactive. Western blotting with antibodies to epitope-tagged ubiquitin molecules confirmed that the up-smearing effect of c-Cbl was due to extensive ubiquitin ligation to EGFR (Fig. 1B, middle panel). As expected, both C381A-Cbl and 70Z-Cbl were unable to induce receptor ubiquitination. Moreover, the basal ubiquitination of EGFR was slightly decreased in the presence of 70Z-Cbl. Despite its inability to induce down-regulation, degradation, and ubiquitination, C381A-Cbl retained physical association with EGFR following ligand stimulation, as was shown by a co-immunoprecipitation experiment (Fig. 1B, lower panel). Likewise, both mutant Cbl proteins exhibited enhanced tyrosine phosphorylation in response to ligand stimulation. In addition, their basal phosphorylation was significantly higher than that of the wild type c-Cbl (Fig. 1C), reminiscent of the elevated phosphorylation of EGFR in cells stably expressing 70Z-Cbl (16). Taken together, the results obtained with the point-mutated Cbl protein indicate that the RF is critically involved in ligand-induced degradation of EGFR and in the preceding ubiquitination step.

View larger version (39K): [in this window] [in a new window]   Fig. 1.   Effect of C381A-Cbl on down-regulation, ubiquitination, and degradation of EGFR. A, CHO cells were transiently transfected with an EGFR expression vector (2 µg) together with plasmids encoding the following proteins: c-Cbl (closed circles), v-Cbl (triangles), 70Z-Cbl (closed squares), or C381A-Cbl (open squares). For control we co-transfected cells with an empty pcDNA3 vector (open circles). Forty-eight hours post-transfection duplicate monolayers were incubated at 37 °C with EGF (100 ng/ml) for the indicated time intervals. Thereafter, the level of surface receptors was determined by incubating the cells for 1.5 h at 4 °C with radiolabeled EGF. B, CHO cells were co-transfected with a plasmid encoding EGFR together with vectors directing expression of the indicated Cbl proteins. An empty vector was used for control (Cont.). All transfections were carried out in the presence of an expression vector encoding a tagged ubiquitin molecule (Ub-HA). Cell monolayers were treated for 10 min at 37 °C without or with EGF (100 ng/ml). Thereafter, cell lysates were prepared and analyzed by immunoprecipitation (IP) and immunoblotting (IB) with the indicated antibodies. C, CHO cells were transfected as described above except that the Ub-HA plasmid was omitted and anti-HA antibodies were used to detect c-Cbl. The open arrow indicates the position of c-Cbl.

C381A-Cbl Inhibits c-Cbl-induced Receptor Ubiquitination-- The ability of the RF mutant of c-Cbl to form a complex with EGFR (Fig. 1B) and to undergo ligand-induced tyrosine phosphorylation (Fig. 1C) implied that it may inhibit interaction of the wild type form of c-Cbl with ligand-stimulated EGFR. Ligand-induced ubiquitin ligation to EGFR was selected as a functional read-out of the interactions between c-Cbl and the activated receptor (1). CHO cells transiently co-overexpressing c-Cbl and EGFR exhibited ligand- and c-Cbl-dependent ubiquitination of EGFR (Fig. 2, upper panel). This effect was significantly inhibited upon co-transfection with a plasmid encoding 70Z-Cbl, but the RF mutant induced a more dramatic inhibitory effect (Fig. 2, middle and lower panels). These differences in efficiency between C381A and 70Z-Cbl proteins may reflect disparate modes of action. Conceivably, the dominant negative effect of C381A-Cbl is due to its binding to EGFR via the uninterrupted phosphotyrosine-binding motif at its NH₂ terminus (4), thereby blocking accessibility of the ubiquitination-competent wild type c-Cbl. However, other mechanisms of inhibition of the wild type protein cannot be excluded. For example, mutagenesis of the RF of Siah-1 abrogated DCC degradation but also stabilized Siah-1 and changed its subcellular localization (15). Besides effects on protein stability and subcellular localization, RF mutagenesis may alter the protein oligomerization state, as is the case with the cancer-disposing mutant of the breast and ovarian cancer tumor suppressor protein, BRCA1. Replacement of one cysteine of the RF of BRCA1 increased proteolytic susceptibility and perturbed the oligomerization properties of BRCA1 in solution (17). We currently investigate the relevance of these potential mechanisms to c-Cbl.

View larger version (37K): [in this window] [in a new window]   Fig. 2.   The C381A-Cbl mutant inhibits EGFR ubiquitination induced by the wild type form of c-Cbl. CHO cells were transiently co-transfected with an EGFR expression vector (2 µg) along with an Ub-HA plasmid (1 µg) and increasing concentrations of a c-Cbl vector. Transfections were performed in the presence of plasmids encoding C381A-Cbl or 70Z-Cbl, as indicated (5 µg each). For control we used an empty vector. Forty-eight hours later cell monolayers were treated for 10 min at 37 °C with or without EGF (100 ng/ml). Subsequently, cell lysates were analyzed by immunoprecipitation with anti-EGFR antibodies and immunoblotting with anti-HA antibodies. The 180-kilodalton region of the gel is shown.

RING Finger Mutagenesis Impairs the Negative Regulatory Role of c-Cbl on Signaling-- Genetic analyses of Cbl/Sli-1 function in C. elegans (2) imply that Cbl proteins normally decrease the potency of EGF signaling through the Ras-MAPK pathway. Therefore we examined the effect of RF mutagenesis on transcriptional activity downstream to this pathway. The SRE of the Fos promoter integrates several signaling pathways, including the Ras-MAPK route (reviewed in Ref. 18). Indeed, when EGFR was transiently expressed in CHO cells, a 2-3-fold stimulation of transcription from the SRE was observed following activation by EGF (Fig. 3A). Co-transfection with the wild-type form of c-Cbl completely blocked the effect of EGF. By contrast, the RF mutant, C381A-Cbl, has lost this negative function, and 70Z-Cbl further enhanced the effect of EGF on transcription from the SRE (Fig. 3A). The disparate effects of the two mutants are reminiscent of the differences observed in other assays (Figs. 1 and 2), and they may be attributed to the type of mutation. Whereas a single residue of the RF was replaced in C381A-Cbl, 17 residues, including Cys-381 and two tyrosines whose function is unknown (19), are deleted in 70Z-Cbl. We next assayed a signaling step preceding SRE transcription, namely MAPK activity. Western blotting of whole cell extracts with a mAb specific to the catalytically active, doubly phosphorylated form of the MAPK/Erk revealed rapid, but transient, stimulation in response to EGF treatment (Fig. 3B). Consistent with the effect on the SRE, overexpression of c-Cbl almost abolished basal and ligand-induced MAPK activity. Both C381A-Cbl and 70Z-Cbl were unable to block MAPK activation (Fig. 3B). In fact, the two proteins weakly, but reproducibly, enhanced the effect of EGF, in accord with their inhibitory effect on down-regulation. It is worth noting that a previous work (16) reported on the ability of 70Z-Cbl to enhance recruitment of several components of the Ras-MAPK pathway (e.g. Grb2, Shc, and Sos1), but no effect on Erk activity was detectable.

View larger version (27K): [in this window] [in a new window]   Fig. 3.   The RING finger of c-Cbl is involved in desensitization of EGFR signaling. A, CHO cells were co-transfected in triplicates with pCDNA3-EGFR (1 µg) along with plasmids encoding the indicated Cbl proteins (each at 1 µg). For control we used empty vectors. All transfections were carried out in the presence of the SRE-luc reporter plasmid (4 µg). Thirty-six hours later cells were untreated or treated with EGF (20 ng/ml). Following twelve additional hours the cells were harvested for a luciferase assay. Signals obtained were normalized to protein concentrations and are presented as average ± S.D. B, CHO cells were transiently transfected with an EGFR expression vector along with plasmids encoding the indicated Cbl proteins or a control plasmid. Cell monolayers were stimulated with EGF (100 ng/ml) for the indicated time intervals at 37 °C. Whole cell lysates were analyzed with an antibody specific to the active doubly phosphorylated form of MAPK.

Recombinant c-Cbl Can Mediate in Vitro Ubiquitination of the EGFR, but the RING Finger Mutant Is Inactive-- The involvement of the RF of c-Cbl in ubiquitination of EGFR in living cells (Figs. 1 and 2) and the recent influx of reports on the direct involvement of RFs in degradation of various substrates (15, 20, 21) prompted us to test C381A-Cbl in a cell-free system. To reconstitute in vitro a c-Cbl-dependent ubiquitin ligation reaction, we immunoprecipitated EGFR from human epidermoid A-431 carcinoma cells, where the receptor is highly overexpressed. The antibody-receptor complexes were extensively washed and then supplemented with bacterially expressed c-Cbl, 70Z-Cbl, or C381A-Cbl fused to GST. To follow its covalent ligation to EGFR we radiolabeled ubiquitin and supplemented the reaction mixture with a reticulocyte lysate, a well characterized rich source of ubiquitin-processing enzymes (22). Following incubation at 30 °C, removal of all reaction components but the substrate and electrophoretic separation, we observed the formation of a complex between the EGFR and ¹²⁵I-ubiquitin molecules (Fig. 4, upper panel). No complex was formed in the absence of ATP, probably due to the necessity to activate ubiquitin by means of adenylation. As expected from our studies with living cells (Fig. 1), neither C381A-Cbl nor 70Z-Cbl were active in vitro, although control experiments verified proper expression and immunological reactivity of the corresponding GST fusion proteins (data not shown). To confirm that the catalytic activity was retained in all samples, we performed an in vitro kinase assay in the presence or absence of labeled ATP (Fig. 4, lower panel). Taken together, the results presented in Fig. 4 imply that the RF domain enables participation of c-Cbl in the three-step ubiquitination reaction (22).

View larger version (41K): [in this window] [in a new window]   Fig. 4.   The RING finger domain of Cbl mediates ubiquitination of isolated EGFR molecules in vitro. Upper panel, immunopurified EGFR was incubated for 60 min at 30 °C with whole rabbit reticulocyte lysate, 125I-ubiquitin, and the indicated GST-Cbl fusion proteins. For control we used bacterial GST alone. An ATP analog was added as noted. At the end of incubation, the immobilized EGFR was washed and resolved by electrophoresis. The resulting autoradiogram is shown along with the location of a 180-kliodalton marker protein (myosin). Lower panel, immunocomplexes were subjected to an in vitro kinase assay, using [-32P]ATP as indicated. Reactions were performed in the presence of the indicated GST-fusion proteins or GST alone. The resulting autoradiogram is shown.

Regardless of the exact role of c-Cbl in the cascade of ubiquitin transfer reactions, our study clearly indicates that an intact RING finger domain is essential for this modification of EGFR. Taken together with previous reports, our present studies propose a structure-function picture of c-Cbl and its family members, Cbl-b (8) and Cbl-3 (9), which share with c-Cbl an extremely well conserved RF. Thus, the NH₂- and COOH-terminal halves of Cbl act as adaptor domains that bind a phosphotyrosine and SH2/3 proteins, respectively, whereas the intervening RF mediates ubiquitination of specific substrates. Because Cbl recruitment to all receptors, including antigen and growth factor receptors, is inducible and depends on receptor phosphorylation or association with phosphorylated proteins (reviewed in Ref. 6), it is likely that the phosphotyrosine-binding domain selects substrates for ubiquitination. Motifs located COOH-terminally to the RF, through their ability to recruit other proteins, either constitutively (e.g. Grb2) or in an inducible manner (e.g. Crk and 14-3-3) may regulate the RF-mediated ubiquitin ligation reaction. Potentially, Cbl regulation may also involve redistribution within the cytoplasm because a fraction of the protein translocates into EGFR-loaded endosomes upon activation by EGF (1). c-Cbl regulation may now be addressed by using the dominant negative mutant we described in this report. Moreover, the in vitro ubiquitination assay we established appears useful for studying c-Cbl and its mutants and homologues in a cell-free system (23). Future studies will have to address the molecular mechanisms underlying RF-induced recruitment of the ubiquitination machinery to tyrosine-phosphorylated substrates and the role played by the many Cbl-associated proteins.

	ACKNOWLEDGEMENTS

We thank Dirk Bohmann for HA-ubiquitin, Wallace Langdon for c-Cbl cDNA, and Sara Lavi for excellent technical assistance.

	FOOTNOTES

^* This work was supported in part by Grant CA-72981 from the National Cancer Institute, National Institutes of Health, the Israel Science Foundation administered by the Israel Academy of Sciences and Humanities, and by a Cancer Research Prize in memory of advocate Sergio Lombroso of Verona.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Biological Regulation, The Weizmann Institute of Science, Rehovot 76100, Israel. Tel.: 972-8-9343974; Fax: 972-8-9342488; E-mail: liyarden@weizmann. weizmann.ac.il.

	ABBREVIATIONS

The abbreviations used are: EGF, epidermal growth factor; EGFR, EGF receptor; CHO, Chinese hamster ovary; GST, gluthatione S-transferase, Ub, ubiquitin; HA, hemagglutinin; mAb, monoclonal antibody; MAPK, mitogen-activated protein kinase; PAGE, polyacrylamide gel electrophoresis; RF, RING finger; SH, Src homology; SRE, serum response element; ATPS, adenosine 5'-O-(thiotriphosphate); DCC, deleted in colon cancer; E1, ubiquitin-activating enzyme; E2, ubiquitin carrier protein; E3, ubiquitin-protein isopeptide ligase.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES